{"nctId":"NCT00125190","briefTitle":"Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency","startDateStruct":{"date":"2005-07"},"conditions":["Insulin-Like Growth Factor-1 Deficiency","Growth Disorders"],"count":45,"armGroups":[{"label":"rhIGF-1 QD","type":"EXPERIMENTAL","interventionNames":["Drug: rhIGF-1 (mecasermin) for a period of 86 weeks"]}],"interventions":[{"name":"rhIGF-1 (mecasermin) for a period of 86 weeks","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Chronological age ≥ 3\n* Chronological age or bone age ≤ 12 for boys and ≤ 11 for girls\n* Prepubertal at Visit 1\n* Height SD score of \\< -2\n* IGF-1 SD score of \\< -2\n\nExclusion Criteria:\n\n* Prior treatment with GH, IGF-1, or other growth-influencing medications\n* Growth failure associated with other identifiable causes (e.g., syndromes, chromosomal abnormality)\n* Chronic illness such as diabetes, cystic fibrosis, etc.","healthyVolunteers":false,"sex":"ALL","minimumAge":"3 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Height Velocity From Pretreatment (Week 0) to Week 34","description":"Height was measured standing without shoes as the average of three measurements by the same observer using identical technique with a Harpenden or other wall mounted stadiometer. The subject was repositioned between each measurement. Height velocity during an interval of time is defined as the change in height during the time interval divided by the duration of the time interval. Missing Week 34 heights were imputed using the last height SD score carried forward.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.0","spread":"1.5"}]}]}]},{"type":"PRIMARY","title":"Height Velocity From Week 34 to 86","description":"Height was measured standing without shoes as the average of three measurements by the same observer using identical technique with a Harpenden or other wall mounted stadiometer. The subject was repositioned between each measurement. Height velocity during an interval of time is defined as the change in height during the time interval divided by the duration of the time interval. Missing Week 86 heights were imputed using the last height SD score carried forward.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7","spread":"1.8"}]}]}]},{"type":"SECONDARY","title":"Change in Height SD Score From Pretreatment to Week 34","description":"Height was measured standing without shoes as the average of three measurements by the same observer using identical technique with a Harpenden or other wall mounted stadiometer. The subject was repositioned between each measurement. The SD score is calculated as the subject value minus the mean divided by the standard deviation. The mean and the standard deviation vary depending on the age and sex of the child.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.21","spread":"0.20"}]}]}]},{"type":"SECONDARY","title":"Change in Height SD Score From Pretreatment to Week 86","description":"Height was measured standing without shoes as the average of three measurements by the same observer using identical technique with a Harpenden or other wall mounted stadiometer. Subjects were repositioned between each measurement. The SD score is calculated as the patient value minus the mean divided by the standard deviation. The mean and the standard deviation vary depending on the age and sex of the child.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.45","spread":"0.39"}]}]}]},{"type":"SECONDARY","title":"Change in Bone Age From Pretreatment to Week 86 Minus Change in Chronological Age","description":"Plain X-rays of the left hand and wrist were exposed for bone age appraisal. The films were sent to a central facility for standardized evaluation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2","spread":"0.68"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Serum Concentration of IGFBP-1, IGFBP-2 and IGFBP-3 From Pretreatment to Week 86","description":"Growth factor panels for measuring IGFBP-1, IGFBP-2 and IGFBP-3 were evaluated from screening and at each study visit up to Week 86. Inter-quartile range (Q1-Q3) is 10th to 90th percentile.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-89.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"37.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change in Serum Concentration of ALS From Pretreatment to Week 86","description":"Growth factor panels for measuring ALS were evaluated from screening and at each study visit up to Week 86. Inter-quartile range (Q1-Q3) is 10th to 90th percentile.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.7","spread":null}]}]}]},{"type":"POST_HOC","title":"Increase in Height Velocity From Pretreatment to Week 34","description":"Height was measured standing without shoes as the average of three measurements by the same observer using identical technique with a Harpenden or other wall mounted stadiometer. The subject was repositioned between each measurement. Height velocity during an interval of time is defined as the change in height during the time interval divided by the duration of the time interval. Missing Week 34 heights were imputed using the last height SD score carried forward.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":"3.56"}]}]}]},{"type":"POST_HOC","title":"Increase in Height Velocity From Pretreatment to Week 86","description":"Height was measured standing without shoes as the average of three measurements by the same observer using identical technique with a Harpenden or other wall mounted stadiometer. The subject was repositioned between each measurement. Height velocity during an interval of time is defined as the change in height during the time interval divided by the duration of the time interval. Missing Week 86 heights were imputed using the last height SD score carried forward.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":"3.58"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":45},"commonTop":["Vomiting","Headache","Pyrexia","Upper Respiratory Tract Infection","Cough"]}}}